1-3 of 3
Heather Rozjabek
Close
Save search
Sort by
Journal Articles

VTE Recurrence and Safety of Anticoagulants Among Patients with Cancer Treated for Venous Thromboembolism

Free
Alok A. Khorana, MD, Keith McCrae, MD, Dejan Milentijevic, Nora McCormick, François Laliberté, Concetta Crivera, Patrick Lefebvre, MA, Dominique Lejeune, Heather Rozjabek, Jeff Schein, Michael B. Streiff
Journal: Blood
Blood (2017) 130 (Supplement 1): 4631.
https://doi.org/10.1182/blood.V130.Suppl_1.4631.4631
Published: 2017
Journal Articles

Healthcare Costs Associated with Venous Thromboembolism in Cancer Patients Treated with Anticoagulants

Free
Michael B. Streiff, Keith McCrae, MD, Dejan Milentijevic, Nora McCormick, François Laliberté, Concetta Crivera, Patrick Lefebvre, MA, Dominique Lejeune, Heather Rozjabek, Jeff Schein, Alok A. Khorana, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4640.
https://doi.org/10.1182/blood.V130.Suppl_1.4640.4640
Published: 2017
Journal Articles

Does the Timing of Vital Sign Measurements Affect Simplified Pulmonary Embolism Severity Index (sPESI) Risk Determination?

Free
Christine G Kohn, PharmD, Heather Rozjabek, MPH, Gregory J Fermann, MD, W Frank Peacock, MD FACEP, Concetta Crivera, Jeff Schein, Craig I Coleman, PharmD
Journal: Blood
Blood (2015) 126 (23): 2058.
https://doi.org/10.1182/blood.V126.23.2058.2058
Published: 2015